Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$17,500.00
Safety and efficacy of a sclerosing and embolizing gel for varicose vein embolization in a porcine model
EF 2021-22
Résumé
Varicose veins are a manifestation of chronic venous disease characterized by reflux of blood in incompetent veins leading to venous dilation.Varicose veins often occur in the lower limb due to failure of the valves of the greater saphenous veins. in addition to pain and aesthetic concerns, varicosities can lead to significant complications such as leg ulcers. The current estimated prevalence of varicose veins in the united states is 15% in men to 28% in women. varicose veins can also be observed in gonadal veins leading to severe abdominal pain in women and testicular pain and infertility in men. A variety of treatments exist for varicose veins. Mechanical techniques such as ligation, surgical stripping and occlusion with mechanical devices block blood flow in the culprit vein preventing reflux, whereas chemical ablation with sclerosing agent and thermal ablation using laser or radiofrequency probes cause damage to the wall of the vein. These methods produce suboptimal results and lead to recurrence of symptoms unless they are used in combination. This leads to redo procedures, increased costs and deterioration of quality of life.Our lab developed and patented an embolizing and sclerosing gel at the CRCHUM composed of chitosan, a bio-absorbable polymer and Sodium Tetradecyl Sulfate, a sclerosing agent. This gel produces simultaneous venous ablation and mechanical occlusion. it is also visible under ultrasound and fluoroscopy which allows for safe delivery under imaging guidance. We aim to test the safety and efficacy of this novel embolizing and sclerosing agent for venous embolization in a porcine model.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466519
Name
Ait ichou Jamal
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Safety and efficacy of a sclerosing and embolizing gel for varicose vein embolization in a porcine model
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomaterial; Chitosan Gel; Chronic Venous Insufficiency; Ct; Embolization; Fluoroscopy; Interventional Radiology; Liquid Embolic; Sclerotherapy; Ultrasound
Abstract
Varicose veins are a manifestation of chronic venous disease characterized by reflux of blood in incompetent veins leading to venous dilation.Varicose veins often occur in the lower limb due to failure of the valves of the greater saphenous veins. in addition to pain and aesthetic concerns, varicosities can lead to significant complications such as leg ulcers. The current estimated prevalence of varicose veins in the united states is 15% in men to 28% in women. varicose veins can also be observed in gonadal veins leading to severe abdominal pain in women and testicular pain and infertility in men. A variety of treatments exist for varicose veins. Mechanical techniques such as ligation, surgical stripping and occlusion with mechanical devices block blood flow in the culprit vein preventing reflux, whereas chemical ablation with sclerosing agent and thermal ablation using laser or radiofrequency probes cause damage to the wall of the vein. These methods produce suboptimal results and lead to recurrence of symptoms unless they are used in combination. This leads to redo procedures, increased costs and deterioration of quality of life.Our lab developed and patented an embolizing and sclerosing gel at the CRCHUM composed of chitosan, a bio-absorbable polymer and Sodium Tetradecyl Sulfate, a sclerosing agent. This gel produces simultaneous venous ablation and mechanical occlusion. it is also visible under ultrasound and fluoroscopy which allows for safe delivery under imaging guidance. We aim to test the safety and efficacy of this novel embolizing and sclerosing agent for venous embolization in a porcine model.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ait ichou, Jamal
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~